(Q30581024)

25 June 2017

1 reference

title

Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors (English)

1 reference

25 June 2017

0 references

1 reference

H B Newton

1

1 reference

25 June 2017

R C Turowski

series ordinal

2

1 reference

25 June 2017

T J Stroup

series ordinal

3

1 reference

25 June 2017

L K McCoy

series ordinal

4

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

Annals of Pharmacotherapy

25 June 2017

1 reference

25 June 2017

33

1 reference

25 June 2017

7-8

1 reference

25 June 2017

816-832

1 reference

25 June 2017

Brain tumors. Part 1.

1 reference

Epidemiology of primary CNS neoplasms

21 January 2018

1 reference

Control of chemotherapy-induced emesis

21 January 2018

1 reference

Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists

21 January 2018

1 reference

Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids

21 January 2018

1 reference

Corticosteroids in cancer: neuropsychiatric complications

21 January 2018

1 reference

Steroid myopathy in cancer patients.

21 January 2018

1 reference

A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors

21 January 2018

1 reference

Oral chemotherapy: rationale and future directions

21 January 2018

1 reference

Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts.

21 January 2018

1 reference

Interstitial chemotherapy for brain tumors: review

21 January 2018

1 reference

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain

21 January 2018

1 reference

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

21 January 2018

1 reference

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

21 January 2018

1 reference

Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review

21 January 2018

1 reference

Quantification and pharmacokinetics of blood-brain barrier disruption in humans

21 January 2018

1 reference

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

21 January 2018

1 reference

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

21 January 2018

1 reference

Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy

21 January 2018

1 reference

Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

21 January 2018

1 reference

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

21 January 2018

1 reference

Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas.

21 January 2018

1 reference

Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine

21 January 2018

1 reference

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure

21 January 2018

1 reference

Intracarotid cisplatin chemotherapy for recurrent gliomas

21 January 2018

1 reference

Intravenous carboplatin for recurrent malignant glioma: a phase II study

21 January 2018

1 reference

Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study

21 January 2018

1 reference

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

21 January 2018

1 reference

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

21 January 2018

1 reference

Tamoxifen and carboplatin combinational treatment of high-grade gliomas. Results of a clinical trial on newly diagnosed patients.

21 January 2018

1 reference

High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children

21 January 2018

1 reference

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide

21 January 2018

1 reference

Salvage chemotherapy for oligodendroglioma.

21 January 2018

1 reference

Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas

21 January 2018

1 reference

The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy

21 January 2018

1 reference

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

21 January 2018

1 reference

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

21 January 2018

1 reference

Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma

21 January 2018

1 reference

Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.

21 January 2018

1 reference

Cisplatin in the treatment of recurrent childhood primary brain tumors.

21 January 2018

1 reference

Carboplatin and recurrent childhood brain tumors

21 January 2018

1 reference

Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.

21 January 2018

1 reference

Combined modality therapy for primary CNS lymphoma

21 January 2018

1 reference

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

21 January 2018

1 reference

Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.

21 January 2018

1 reference

Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study

21 January 2018

1 reference

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group

21 January 2018

1 reference

Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma

21 January 2018

1 reference

Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

21 January 2018

1 reference

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna

21 January 2018

1 reference

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa

21 January 2018

1 reference

Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

21 January 2018

1 reference

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

21 January 2018

1 reference

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

21 January 2018

1 reference

Successful chemotherapy for recurrent malignant oligodendroglioma.

21 January 2018

1 reference

VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.

21 January 2018

1 reference

Solution structure of a cisplatin-induced DNA interstrand cross-link

21 January 2018

1 reference

A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.

21 January 2018

1 reference

Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study

21 January 2018

1 reference

Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors

21 January 2018

1 reference

Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium

21 January 2018

1 reference

Intra-arterial cisplatin for the treatment of malignant gliomas.

21 January 2018

1 reference

Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures

21 January 2018

1 reference

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

21 January 2018

1 reference

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

21 January 2018

1 reference

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

21 January 2018

1 reference

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

21 January 2018

1 reference

Cytarabine and neurologic toxicity

21 January 2018

1 reference

Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance

21 January 2018

1 reference

Clinical outcome in aggressively treated meningeal gliomatosis

21 January 2018

1 reference

Mechanism of action of antitumor drug etoposide: a review

21 January 2018

1 reference

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

21 January 2018

1 reference

Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors

21 January 2018

1 reference

The current status of camptothecin analogues as antitumor agents

21 January 2018

1 reference

Phase II evaluation of topotecan for pediatric central nervous system tumors.

21 January 2018

1 reference

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

21 January 2018

1 reference

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

21 January 2018

1 reference

Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.

21 January 2018

1 reference

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

21 January 2018

1 reference

Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action

21 January 2018

1 reference

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

21 January 2018

1 reference

Recent advances in understanding the molecular mechanisms of tamoxifen action

21 January 2018

1 reference

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

21 January 2018

1 reference

High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.

21 January 2018

1 reference

21 January 2018

1 reference

Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors.

21 January 2018

1 reference

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

21 January 2018

1 reference

Phase II study of paclitaxel in patients with recurrent malignant glioma.

21 January 2018

1 reference

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

Angiogenesis in brain tumors; pathobiological and clinical aspects

21 January 2018

1 reference

Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

21 January 2018

1 reference

Expression and distribution of vascular endothelial growth factor protein in human brain tumors

21 January 2018

1 reference

The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.

21 January 2018

1 reference

Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system

21 January 2018

1 reference

Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system

21 January 2018

1 reference

Thymidine kinase-mediated killing of rat brain tumors

21 January 2018

1 reference

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

21 January 2018

1 reference

Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line.

21 January 2018

1 reference

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

21 January 2018

1 reference

What is the etiology of human brain tumors? A report on the first Lebow conference

21 January 2018

1 reference

Constipation in the cancer patient: causes and management.

21 January 2018

1 reference

Mechanisms of tumor-associated edema: a review.

21 January 2018

1 reference

Corticosteroid toxicity in neuro-oncology patients

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

New antiepileptic drugs

1 reference

Chemotherapy for malignant gliomas

21 January 2018

1 reference

The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo pr

21 January 2018

1 reference

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

21 January 2018

1 reference

High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases

21 January 2018

1 reference

Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD

21 January 2018

1 reference

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

21 January 2018

1 reference

Hormonal manipulation of meningiomas in vitro

21 January 2018

1 reference

Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms

21 January 2018

1 reference

21 January 2018

Gene therapy of cancer

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18353

1 reference

25 June 2017

1 reference